TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MAXHEALTH Stock 12 Month Forecast
There Are No Analyst Ratings for IN:MAXHEALTH In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
MAXHEALTH Financial Forecast
MAXHEALTH Earnings Forecast
Next quarter’s earnings estimate for MAXHEALTH is ₹4.70 with a range of ₹4.01 to ₹5.28. The previous quarter’s EPS was ₹5.02. MAXHEALTH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.
Next quarter’s earnings estimate for MAXHEALTH is ₹4.70 with a range of ₹4.01 to ₹5.28. The previous quarter’s EPS was ₹5.02. MAXHEALTH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.
MAXHEALTH Sales Forecast
Next quarter’s sales forecast for MAXHEALTH is ₹26.81B with a range of ₹26.28B to ₹27.34B. The previous quarter’s sales results were ₹21.35B. MAXHEALTH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.
Next quarter’s sales forecast for MAXHEALTH is ₹26.81B with a range of ₹26.28B to ₹27.34B. The previous quarter’s sales results were ₹21.35B. MAXHEALTH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year MAXHEALTH has Performed in-line its overall industry.
Max Healthcare Institute Ltd (MAXHEALTH) Gets a Buy from JefferiesJefferies analyst Alok Dalal raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,500.00 (from INR1,400.00) while maintaining a Buy rating.
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,325 at JPMorganJPMorgan analyst Bansi Desai lowered the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,325.00 (from INR1,390.00) while maintaining a Overweight rating.
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,170 at BofA SecuritiesBofA Securities analyst Neha Manpuria raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,170.00 (from INR1,100.00) while maintaining a Neutral rating.
Macquarie Reiterates Underperform Rating on Max Healthcare Institute Ltd (MAXHEALT:IN)Macquarie analyst Kunal Dhamesha reiterated an Underperform rating and INR615.00 price target on Max Healthcare Institute Ltd (MAXHEALT:IN).
Max Healthcare Institute Ltd (MAXHEALTH) Gets a Buy from JefferiesJefferies analyst Alok Dalal raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,500.00 (from INR1,400.00) while maintaining a Buy rating.
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Lowered to INR1,325 at JPMorganJPMorgan analyst Bansi Desai lowered the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,325.00 (from INR1,390.00) while maintaining a Overweight rating.
Max Healthcare Institute Ltd (MAXHEALT:IN) PT Raised to INR1,170 at BofA SecuritiesBofA Securities analyst Neha Manpuria raised the price target on Max Healthcare Institute Ltd (MAXHEALT:IN) to INR1,170.00 (from INR1,100.00) while maintaining a Neutral rating.
Macquarie Reiterates Underperform Rating on Max Healthcare Institute Ltd (MAXHEALT:IN)Macquarie analyst Kunal Dhamesha reiterated an Underperform rating and INR615.00 price target on Max Healthcare Institute Ltd (MAXHEALT:IN).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 100.00% of your transactions generating a profit, with an average return of +8.93% per trade.
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +5.30% per trade.
Copying Alankar Garude's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +10.93% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +10.93% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MAXHEALTH Analyst Recommendation Trends
Rating
May 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
1
2
4
3
2
Hold
2
3
6
7
7
Sell
2
1
1
1
1
Strong Sell
0
0
0
0
0
total
5
6
11
11
10
In the current month, MAXHEALTH has received 2Buy Ratings, 7Hold Ratings, and 1Sell Ratings. MAXHEALTH average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
MAXHEALTH Stock Forecast FAQ
What is IN:MAXHEALTH’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:MAXHEALTH’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:MAXHEALTH, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Max Healthcare Institute Ltd a Buy, Sell or Hold?
Currently, no data Available
What is Max Healthcare Institute Ltd’s share price target?
Currently, no data Available
What do analysts say about Max Healthcare Institute Ltd?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Max Healthcare Institute Ltd?
To buy shares of IN:MAXHEALTH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.